{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:39:18Z","timestamp":1764790758958,"version":"3.46.0"},"reference-count":31,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Context.\u2014Although the loss of B-lineage\u2013specific gene expression is a distinctive feature of plasmablastic lymphoma, the underlying mechanism remains poorly understood. A candidate for this mechanism is Notch1 signaling, which interferes with the activity of B-cell\u2013specific transcription factors E2A and early B-cell factor and positively regulates the mammalian target of rapamycin (mTOR) pathway.<\/jats:p>\n                  <jats:p>Objective.\u2014To explore the mechanism of loss of B-cell phenotype by correlating expression of B-cell markers with that of Notch1 and downstream targets of the mTOR pathway in plasmablastic lymphoma.<\/jats:p>\n                  <jats:p>Design.\u2014A combination of flow cytometric and immunohistochemical immunophenotyping techniques was used on 9 cases of plasmablastic lymphoma to correlate loss of B-cell markers with expression of Notch1 and downstream activation of the mTOR pathway. These results are compared with 5 cases of primary effusion lymphoma and 21 cases of plasma cell myeloma.<\/jats:p>\n                  <jats:p>Results.\u2014Plasmablastic lymphoma cases exhibit nearly complete loss of B-cell\u2013associated markers and uniform expression of Notch1, with a predominantly nuclear staining pattern. There is a concurrent activation of the mTOR pathway, indicated by expression of mTOR targets eukaryotic initiation factor 4E\u2013binding protein 1 and phosphorylated ribosomal protein S6 in most cases. Similar results are seen in cases of primary effusion lymphoma and plasma cell myeloma.<\/jats:p>\n                  <jats:p>Conclusions.\u2014These findings suggest that activation of Notch1 may be involved in suppression of B-cell\u2013specific gene expression and global loss of the B-cell phenotype in plasmablastic lymphoma, similar to primary effusion lymphoma and plasma cell myeloma. Thus, there might be a role for the Notch1 and mTOR pathways in the pathogenesis and therapy of plasmablastic lymphoma.<\/jats:p>","DOI":"10.5858\/2009-0691-oa.1","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T13:34:17Z","timestamp":1613136857000},"page":"770-775","source":"Crossref","is-referenced-by-count":4,"title":["Uniform Expression of Notch1, Suppressor of B-Cell\u2013Specific Gene Expression, in Plasmablastic Lymphoma"],"prefix":"10.5858","volume":"135","author":[{"given":"Adam C.","family":"Seegmiller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-You","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Hladik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"4","key":"2021021104304731200_i1543-2165-135-6-770-b01","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection.","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"issue":"10","key":"2021021104304731200_i1543-2165-135-6-770-b02","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.21250","article-title":"HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.","volume":"83","author":"Castillo","year":"2008","journal-title":"Am J Hematol"},{"issue":"1","key":"2021021104304731200_i1543-2165-135-6-770-b03","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1601-0825.2008.01493.x","article-title":"Plasmablastic lymphoma: a review.","volume":"15","author":"Rafaniello Raviele","year":"2009","journal-title":"Oral Dis"},{"key":"2021021104304731200_i1543-2165-135-6-770-b04","first-page":"256","article-title":"Plasmablastic lymphoma.","author":"Stein","year":"2008","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed"},{"issue":"6","key":"2021021104304731200_i1543-2165-135-6-770-b05","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogenous group of disease entities.","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2021021104304731200_i1543-2165-135-6-770-b06","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2559.2007.02870.x","article-title":"Plasmablastic lymphoma may occur as post-transplant lymphoproliferative disorders.","volume":"51","author":"Borenstein","year":"2007","journal-title":"Histopathology"},{"issue":"2","key":"2021021104304731200_i1543-2165-135-6-770-b07","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ajcp\/105.2.221","article-title":"Primary body cavity-based AIDS-related lymphomas.","volume":"105","author":"Ansari","year":"1996","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2021021104304731200_i1543-2165-135-6-770-b08","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi sarcoma-associated herpes virus.","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"issue":"4","key":"2021021104304731200_i1543-2165-135-6-770-b09","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2021021104304731200_i1543-2165-135-6-770-b10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nri1633","article-title":"Transcriptional networks in developing and mature B cells.","volume":"5","author":"Matthias","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2021021104304731200_i1543-2165-135-6-770-b11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1074-7613(00)80105-3","article-title":"Notch1 expression in early lymphopoiesis influences B versus T lineage determination.","volume":"11","author":"Pui","year":"1999","journal-title":"Immunity"},{"issue":"6","key":"2021021104304731200_i1543-2165-135-6-770-b12","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1182\/blood-2004-12-4744","article-title":"Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development.","volume":"106","author":"Smith","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2021021104304731200_i1543-2165-135-6-770-b13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1242\/dev.01074","article-title":"Notch signaling: control of cell communication and cell fate.","volume":"131","author":"Lai","year":"2004","journal-title":"Development"},{"issue":"1","key":"2021021104304731200_i1543-2165-135-6-770-b14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.gde.2006.12.001","article-title":"The multifaceted role of Notch in cancer.","volume":"17","author":"Roy","year":"2007","journal-title":"Curr Opin Genet Dev"},{"issue":"9","key":"2021021104304731200_i1543-2165-135-6-770-b15","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1158\/0008-5472.CAN-05-3830","article-title":"Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.","volume":"66","author":"Mungamuri","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"2021021104304731200_i1543-2165-135-6-770-b16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2006-08-039883","article-title":"Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia.","volume":"110","author":"Chan","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2021021104304731200_i1543-2165-135-6-770-b17","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","article-title":"Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma.","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"issue":"8","key":"2021021104304731200_i1543-2165-135-6-770-b18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/leu.2008.101","article-title":"Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.","volume":"22","author":"Jundt","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"2021021104304731200_i1543-2165-135-6-770-b19","first-page":"217","article-title":"Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.","volume":"44","author":"Chang","year":"2006","journal-title":"J Microbiol"},{"issue":"2","key":"2021021104304731200_i1543-2165-135-6-770-b20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.virol.2006.03.047","article-title":"Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.","volume":"351","author":"Lan","year":"2006","journal-title":"Virology"},{"issue":"13","key":"2021021104304731200_i1543-2165-135-6-770-b21","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/JVI.00239-06","article-title":"Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro.","volume":"80","author":"Lan","year":"2006","journal-title":"J Virol"},{"issue":"6","key":"2021021104304731200_i1543-2165-135-6-770-b22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.2010.67","article-title":"Notch1 in primary effusion lymphoma: a clinicopathologic study.","volume":"23","author":"Wang","year":"2010","journal-title":"Mod Pathol"},{"issue":"9","key":"2021021104304731200_i1543-2165-135-6-770-b23","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2003-07-2254","article-title":"Jagged-1 induced Notch signaling drives proliferation of multiple myeloma cells.","volume":"103","author":"Jundt","year":"2004","journal-title":"Blood"},{"issue":"2","key":"2021021104304731200_i1543-2165-135-6-770-b24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.pai.0000129055.93199.2b","article-title":"The t(14;18) in diffuse large B-cell lymphoma: correlation with germinal center-associated markers and clinical features.","volume":"13","author":"Xu","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"2021021104304731200_i1543-2165-135-6-770-b25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1309\/6UGDU03VVD0L98LQ","article-title":"Characterization of incidentally identified minute clonal B-lymphocytes populations in peripheral blood and bone marrow.","volume":"122","author":"Chen","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2021021104304731200_i1543-2165-135-6-770-b26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cellsig.2009.01.004","article-title":"Akt-dependent and independent mechanisms of mTOR regulation in cancer.","volume":"21","author":"Memmott","year":"2009","journal-title":"Cell Signal"},{"issue":"4","key":"2021021104304731200_i1543-2165-135-6-770-b27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1309\/AJCPFUR1BK0UODTS","article-title":"Plasmablastic lymphomas with MYC\/IgH rearrangement: report of three cases and review of the literature.","volume":"132","author":"Bogusz","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"2021021104304731200_i1543-2165-135-6-770-b28","first-page":"260","article-title":"Primary effusion lymphoma.","author":"Said","year":"2008","journal-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed"},{"issue":"11","key":"2021021104304731200_i1543-2165-135-6-770-b29","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.88.11.4766","article-title":"Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.","volume":"88","author":"Herbst","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20133","key":"2021021104304731200_i1543-2165-135-6-770-b30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0171-2985(97)80050-2","article-title":"Both Epstein-Barr viral nuclear antigen 2 (EBNA-2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.","volume":"198","author":"Strobl","year":"1997","journal-title":"Immunobiology"},{"issue":"15","key":"2021021104304731200_i1543-2165-135-6-770-b31","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1101\/gad.996502","article-title":"The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.","volume":"16","author":"Liang","year":"2002","journal-title":"Genes Dev"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/135\/6\/770\/2771121\/2009-0691-oa_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/135\/6\/770\/2771121\/2009-0691-oa_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:33:18Z","timestamp":1764790398000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/135\/6\/article-p770.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,1]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/2009-0691-oa.1","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"type":"electronic","value":"1543-2165"},{"type":"print","value":"0003-9985"}],"subject":[],"published":{"date-parts":[[2011,6,1]]}}}